Literature DB >> 10912521

Effects of IGFBP-2 overexpression in vitro and in vivo.

E Wolf1, H Lahm, M Wu, R Wanke, A Hoeflich.   

Abstract

Insulin-like growth factor-binding proteins (IGFBPs) are important modulators of IGF actions and may have both stimulatory and inhibitory effects. Expression of IGFBP-2 is increased after fasting and in a variety of pathological conditions. However, the specific role of IGFBP-2 in growth physiology remains to be determined. In this review, we summarize data from in vitro and in vivo models suggesting that IGFBP-2 has mainly inhibitory effects on IGF actions. Since the growth hormone (GH)/IGF system is involved in a number of pathological alterations of the kidney and these changes may--at least in part--be due to increased IGF-I, local overexpression of inhibitory IGFBP-2 in the kidney might prevent IGF-I-induced lesions. This hypothesis will be tested by crossing GH transgenic mice, a common model of glomerulosclerosis, with transgenic mice characterized by systemic and renal overexpression of IGFBP-2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10912521     DOI: 10.1007/s004670000362

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women.

Authors:  Jon J Ladd; Tina Busald; Melissa M Johnson; Qing Zhang; Sharon J Pitteri; Hong Wang; Dean E Brenner; Paul D Lampe; Raju Kucherlapati; Ziding Feng; Ross L Prentice; Samir M Hanash
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-25

2.  Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease.

Authors:  Marusia Lilova; Bernard S Kaplan; Kevin E C Meyers
Journal:  Pediatr Nephrol       Date:  2002-11-26       Impact factor: 3.714

Review 3.  Growth hormone/insulin-like growth factor system in children with chronic renal failure.

Authors:  Burkhard Tönshoff; Daniela Kiepe; Sonia Ciarmatori
Journal:  Pediatr Nephrol       Date:  2005-02-04       Impact factor: 3.714

4.  Systemic overexpression of growth hormone (GH) in transgenic FVB/N inbred mice: an optimized model for holistic studies of molecular mechanisms underlying GH-induced kidney pathology.

Authors:  Dagmar C von Waldthausen; Marlon R Schneider; Ingrid Renner-Müller; Dirk N Rauleder; Nadja Herbach; Bernhard Aigner; Rüdiger Wanke; Eckhard Wolf
Journal:  Transgenic Res       Date:  2007-12-20       Impact factor: 2.788

5.  Interaction of insulin-like growth factor-binding protein 2 with α2-macroglobulin in the circulation.

Authors:  Miloš Šunderić; Goran Miljuš; Olgica Nedić
Journal:  Protein J       Date:  2013-02       Impact factor: 2.371

6.  Angiotensin II- and glucose-stimulated extracellular matrix production: mediation by the insulin-like growth factor (IGF) axis in a murine mesangial cell line.

Authors:  Lori K Davis; Buel D Rodgers; Kevin M Kelley
Journal:  Endocrine       Date:  2008-04-08       Impact factor: 3.633

7.  Insulin-like growth factors in patients with liver cysts.

Authors:  Olgica Nedić; J Anna Nikolić; Ivona Baricević; Biljana Jovanović; Natasa Ilić
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

8.  Antibody-Array-Based Proteomic Screening of Serum Markers in Systemic Lupus Erythematosus: A Discovery Study.

Authors:  Tianfu Wu; Huihua Ding; Jie Han; Cristina Arriens; Chungwen Wei; Weilu Han; Claudia Pedroza; Shan Jiang; Jennifer Anolik; Michelle Petri; Ignacio Sanz; Ramesh Saxena; Chandra Mohan
Journal:  J Proteome Res       Date:  2016-06-07       Impact factor: 4.466

Review 9.  Insulin-Like Growth Factor Binding Proteins in Kidney Disease.

Authors:  Shuqiang Wang; Kun Chi; Di Wu; Quan Hong
Journal:  Front Pharmacol       Date:  2021-12-22       Impact factor: 5.810

10.  Growth hormone (GH)-transgenic insulin-like growth factor 1 (IGF1)-deficient mice allow dissociation of excess GH and IGF1 effects on glomerular and tubular growth.

Authors:  Andreas Blutke; Marlon R Schneider; Eckhard Wolf; Rüdiger Wanke
Journal:  Physiol Rep       Date:  2016-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.